AAMC Advisory Panel on Research
I recently had the fortune to be asked to be part of AAMC (Association of American Medical College's) Advisory Panel on Research.
This Advisory Panel is made of approximately 15-20 research leaders across the nation who get together to discuss contemporary issues in academic medicine. At this meeting, we addressed two major topics: transparency of clinical trial data and changes at the NIH. For the discussion on making clinical trial data more available and transparent to the public, we started with a panel of experts with representatives from a patient perspective, industry perspective and an expert from ClinicalTrials.gov. All agreed that having research data more widely available is advantageous to the field; the challenges are in the logistics and maintaining confidentiality. The second part was a report and discuss led by Sally Rockey, the Deputy Director for Extramural Research at the NIH (who also writes a very popular blog). This was very informative to understand the history of NIH funding, their goals and considerations to achieve those goals. The meeting ended with an advocacy update as it relates to research.
Overall, I found the meeting very informative and a great chance to meet several others who lead up the research efforts for their universities and hospitals. It was also a great opportunity to share with this prestigious group the great work happening across the MedStar-Georgetown research community.
This Advisory Panel is made of approximately 15-20 research leaders across the nation who get together to discuss contemporary issues in academic medicine. At this meeting, we addressed two major topics: transparency of clinical trial data and changes at the NIH. For the discussion on making clinical trial data more available and transparent to the public, we started with a panel of experts with representatives from a patient perspective, industry perspective and an expert from ClinicalTrials.gov. All agreed that having research data more widely available is advantageous to the field; the challenges are in the logistics and maintaining confidentiality. The second part was a report and discuss led by Sally Rockey, the Deputy Director for Extramural Research at the NIH (who also writes a very popular blog). This was very informative to understand the history of NIH funding, their goals and considerations to achieve those goals. The meeting ended with an advocacy update as it relates to research.
Overall, I found the meeting very informative and a great chance to meet several others who lead up the research efforts for their universities and hospitals. It was also a great opportunity to share with this prestigious group the great work happening across the MedStar-Georgetown research community. 
Comments
Post a Comment